Description
Ipratropium is an acetylcholine antagonist via blockade of muscarinic cholinergic receptors. Blocking cholinergic receptors decreases the production of cyclic guanosine monophosphate (cGMP). This decrease in the lung airways will lead to decreased contraction of the smooth muscles.
Ingredients
Ipratropium Bromide
Drug Class
Bronchodilator
Dosage Form
Inhaler
Uses
Ipratropium Bromide is utilized for the following therapeutic indications:
- Treatment of chronic obstructive pulmonary disease (COPD)
- Relief of bronchospasm in asthma patients
- Administered via inhalation for quick onset of action
- Reduces mucus secretion in the airways
- Often used in combination with other bronchodilators for enhanced efficacy
Reviews
There are no reviews yet.